These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25831061)
1. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer? Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of soy phytoestrogens and 17β-estradiol on DNA methylation of a panel of 24 genes in prostate cancer cell lines. Adjakly M; Ngollo M; Lebert A; Dagdemir A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D Nutr Cancer; 2014; 66(3):474-82. PubMed ID: 24641702 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Adjakly M; Bosviel R; Rabiau N; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D Epigenomics; 2011 Dec; 3(6):795-803. PubMed ID: 22126297 [TBL] [Abstract][Full Text] [Related]
4. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? Bosviel R; Dumollard E; Déchelotte P; Bignon YJ; Bernard-Gallon D OMICS; 2012 May; 16(5):235-44. PubMed ID: 22339411 [TBL] [Abstract][Full Text] [Related]
5. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. Vardi A; Bosviel R; Rabiau N; Adjakly M; Satih S; Dechelotte P; Boiteux JP; Fontana L; Bignon YJ; Guy L; Bernard-Gallon DJ In Vivo; 2010; 24(4):393-400. PubMed ID: 20668305 [TBL] [Abstract][Full Text] [Related]
6. miRNAs differentially expressed in prostate cancer cell lines after soy treatment. Rabiau N; Trraf HK; Adjakly M; Bosviel R; Guy L; Fontana L; Bignon YJ; Bernard-Gallon DJ In Vivo; 2011; 25(6):917-21. PubMed ID: 22021684 [TBL] [Abstract][Full Text] [Related]
7. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone. Dong X; Xu W; Sikes RA; Wu C Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911 [TBL] [Abstract][Full Text] [Related]
8. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray. Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672 [TBL] [Abstract][Full Text] [Related]
9. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines. Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D Epigenomics; 2013 Feb; 5(1):51-63. PubMed ID: 23414320 [TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms. Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763 [TBL] [Abstract][Full Text] [Related]
11. Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. Handayani R; Rice L; Cui Y; Medrano TA; Samedi VG; Baker HV; Szabo NJ; Shiverick KT J Nutr; 2006 Jan; 136(1):75-82. PubMed ID: 16365062 [TBL] [Abstract][Full Text] [Related]
12. Prostate cancer: The main risk and protective factors-Epigenetic modifications. Adjakly M; Ngollo M; Dagdemir A; Judes G; Pajon A; Karsli-Ceppioglu S; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D Ann Endocrinol (Paris); 2015 Feb; 76(1):25-41. PubMed ID: 25592466 [TBL] [Abstract][Full Text] [Related]
13. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Majid S; Igawa M; Dahiya R Int J Cancer; 2008 Aug; 123(3):552-60. PubMed ID: 18431742 [TBL] [Abstract][Full Text] [Related]
14. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells. Raschke M; Wähälä K; Pool-Zobel BL Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846 [TBL] [Abstract][Full Text] [Related]
15. Genistein and daidzein: different molecular effects on prostate cancer. Adjakly M; Ngollo M; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D Anticancer Res; 2013 Jan; 33(1):39-44. PubMed ID: 23267126 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Rietjens IM; Sotoca AM; Vervoort J; Louisse J Mol Nutr Food Res; 2013 Jan; 57(1):100-13. PubMed ID: 23175102 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells. Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023 [TBL] [Abstract][Full Text] [Related]
18. The Role of Soy Phytoestrogens on Genetic and Epigenetic Mechanisms of Prostate Cancer. Karsli-Ceppioglu S; Ngollo M; Judes G; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D Enzymes; 2015; 37():193-221. PubMed ID: 26298461 [TBL] [Abstract][Full Text] [Related]
19. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Suzuki K; Koike H; Matsui H; Ono Y; Hasumi M; Nakazato H; Okugi H; Sekine Y; Oki K; Ito K; Yamamoto T; Fukabori Y; Kurokawa K; Yamanaka H Int J Cancer; 2002 Jun; 99(6):846-52. PubMed ID: 12115487 [TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic regulations of prostate cancer by genistein. Molinié B; Georgel P Drug News Perspect; 2009 Jun; 22(5):247-54. PubMed ID: 19609462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]